Sort
46,585 grants matching “heart failure”
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
$393,156Casey Crump · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · HL
The Cardiac Role of Filamin C
$393,125Ju Chen · University Of California, San Diego · R01 · FY2019 · HL
SOCS-1 and endothelial dysfunction in graft arteriosclerosis
$393,102Wang Min · Yale University · P01 · FY2010 · HL
UMass Center for Building the Science of Symptom Self-Management (UManage Center)
$393,092Cynthia S Jacelon · University Of Massachusetts Amherst · P20 · FY2017 · NR
Comprehensive in vivo MRI of mouse embryonic stem cell myocardial engraftment
$393,078Phillip Chung-Ming Yang · Stanford University · R01 · FY2012 · HL
Mechanisms of Oxidant Signaling in Post-MI Remodeling
$393,041Wilson S. Colucci · Boston Medical Center · R01 · FY2006 · HL
Angiotensin Converting Enzyme Gene Expression
$393,027Cleveland Clinic Foundation · R01 · FY2003 · HL
The effect of voluntary bundled payments on vulnerable populations
$393,021Amol S Navathe · University Of Pennsylvania · R01 · FY2023 · HS
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodeling
$393,020Joan Heller Brown · University Of California, San Diego · R01 · FY2019 · HL
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$393,018Joseph C Wu · Stanford University · R01 · FY2016 · HL
MOLECULAR DISTRIBUTION OF HUMAN ADRENERGIC RECEPTORS
$393,003Duke University · R01 · FY2003 · HL
BIOENGINEERING-BIOLOGIC STUDY OF NON-PULSATILE PERFUSION
$393,002University Of Maryland Baltimore · R01 · FY2003 · EB
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis
$393,000Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
Mechanism of ApoA1 Lipidation by ABCA1 in HDL biogenesis
$393,000Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Precision Medicine for Dilated CardiomyopathyâNovel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early Phenotypes
$392,992Ray E Hershberger · Ohio State University · R01 · FY2022 · HL
Precision Medicine for Dilated CardiomyopathyâNovel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early Phenotypes
$392,961Ray E Hershberger · Ohio State University · R01 · FY2021 · HL
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$392,944Joseph C Wu · Stanford University · R01 · FY2012 · HL
Non-Invasive Venous waveform Analysis (NIVA) for Monitoring Volume Status in Heart Failure Patients
$392,932Bret D Alvis · Vanderbilt University Medical Center · R01 · FY2024 · HL
Precision Medicine for Dilated CardiomyopathyâNovel Assessment of Cardiac Mechanics via Speckle Tracking Echocardiography to Identify Early Phenotypes
$392,930Ray E Hershberger · Ohio State University · R01 · FY2020 · HL
Mechanisms Underlying the Progression of Arterial Stiffness in Hypertension
$392,805Jay D Humphrey · Yale University · R01 · FY2011 · HL
Predicting and preventing drug metabolism by the human gut microbiome
$392,803Peter James Turnbaugh · University Of California, San Francisco · R01 · FY2018 · HL
Project 1: Implications of blood cell heterogeneity for CV disease
$392,801David T Scadden · Massachusetts General Hospital · P01 · FY2023 · HL
Project 1: Implications of blood cell heterogeneity for CV disease
$392,801David T Scadden · Massachusetts General Hospital · P01 · FY2019 · HL
Project 1: Implications of blood cell heterogeneity for CV disease
$392,801David T Scadden · Massachusetts General Hospital · P01 · FY2022 · HL
Project 1: Implications of blood cell heterogeneity for CV disease
$392,800David T Scadden · Massachusetts General Hospital · P01 · FY2021 · HL